HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yizhi capsule for vascular dementia.

AbstractBACKGROUND:
Vascular dementia (VD) is a syndrome or diagnosis that has different causes and clinical manifestations relating to several different vascular mechanisms and changes in the brain. Some traditional Chinese herbal medicines were developed for treating VD. DH: Yizhi capsule is one such herbal concoction which is reported to improve clinical symptoms significantly. The efficacy and adverse effects of Yizhi capsule need to be reviewed systematically and assessed critically to inform clinical practice and guide the continued search for new treatment regimens.
OBJECTIVES:
To assess the effectiveness and possible adverse events of 'Yizhi capsule' in treating vascular dementia.
SEARCH STRATEGY:
The Cochrane Dementia and Cognitive Improvement Group's Specialised Register was searched on 18 September 2006 using the terms yi-zhi, "yi zhi" and yizhi. This database contains trial references from major health care databases and ongoing trial database and is up to date. In addition the review authors searched a variety of Chinese databases.
SELECTION CRITERIA:
Randomised, placebo controlled trials in which patients with vascular dementia were treated with 'Yizhi capsule' were included.
DATA COLLECTION AND ANALYSIS:
Two authors independently assessed trial quality and extracted data. We telephoned study authors for missing information as to whether treatment allocation was randomised and other methodological details.
MAIN RESULTS:
No studies were found that met the inclusion criteria. We identified nine references to trials which included the term 'Yizhi capsule' in the description of the interventions. Two study authors were contacted by telephone and we discovered that the allocation methods they had used were not actually randomised. Four references were describing the same study. Three studies were excluded because 'positive drugs' were used as a control.
AUTHORS' CONCLUSIONS:
There is no evidence from randomised controlled trials to support or proscribe against the use of 'Yizhi capsule' as a treatment for vascular dementia.
AuthorsT X Wu, Q P Li, Z Y Yuan
JournalThe Cochrane database of systematic reviews (Cochrane Database Syst Rev) Issue 2 Pg. CD005382 (Apr 18 2007) ISSN: 1469-493X [Electronic] England
PMID17443586 (Publication Type: Journal Article, Review, Systematic Review)
Chemical References
  • Alpinia oxyphylla fruit extract
  • Capsules
  • Drugs, Chinese Herbal
  • Plant Extracts
Topics
  • Alpinia
  • Capsules
  • Dementia, Vascular (drug therapy)
  • Drugs, Chinese Herbal (therapeutic use)
  • Humans
  • Phytotherapy (methods)
  • Plant Extracts

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: